What is MaxCyte's operating income?

MaxCyte (MXCT) reported operating income of -$6.19M in Q1 2026.

How has MaxCyte's operating income changed year-over-year?

MaxCyte's operating income increased by 49.7% year-over-year, from -$12.3M to -$6.19M.

What is the long-term trend for MaxCyte's operating income?

Over 4 years (2021 to 2025), MaxCyte's operating income has grown at a 30.0% compound annual growth rate (CAGR), from -$18.19M to -$51.9M.

What does operating income mean?

Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.

MaxCyte MXCT Operating Income

Operating Income at other companies

Bio-Rad LaboratoriesBIO

$34.1M+43.9%

Thermo Fisher ScientificTMO

$1.86B+8.6%

Ginkgo BioworksDNA

-$71.37M+11.9%

Immix Biopharma, Inc.IMMX

-$10.8M-131%

Rapid Micro BiosystemsRPID

-$13.85M-18.8%

PDE

Pro-Dex, Inc.PDEX

$3.09M-15.0%

Other financials

Income statement

See full

Revenue$9.7M-7.1%

Gross profit$8.1M-9.1%

Net income-$4.8M+53.7%

EPS (diluted)-$0.04+60.0%

Balance sheet

See full

Cash & equivalents$14.6M-37.8%

Total debt$17.5M-7.1%

Total equity$167.9M-15.8%

Total assets$194.5M-15.4%

Cash flow

See full

Operating cash flow-$8.2M+43.3%

CapEx$72.0K-89.0%

Free cash flow-$8.2M+45.3%

Valuation

See full

Market cap$130.15M-46.8%

Enterprise value$133.08M-46.3%

P/S4×-2.8×

Profitability

See full

Gross margin80.5%-0.4pp

Operating margin-141.8%+6.4pp

Net margin-121.2%+12.3pp

FCF margin-90.9%+3.7pp

Returns & leverage

See full

Return on equity-21.3%+2.0pp

Debt / equity0.1×0.0×

Current ratio12×-0.2×

Where this comes from

Reported directly by MaxCyte in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: MaxCyte’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about MaxCyte's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MaxCyte's operating income?: MaxCyte (MXCT) reported operating income of -$6.19M in Q1 2026.
How has MaxCyte's operating income changed year-over-year?: MaxCyte's operating income increased by 49.7% year-over-year, from -$12.3M to -$6.19M.
What is the long-term trend for MaxCyte's operating income?: Over 4 years (2021 to 2025), MaxCyte's operating income has grown at a 30.0% compound annual growth rate (CAGR), from -$18.19M to -$51.9M.
What does operating income mean?: Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.